Command Palette

Search for a command to run...

KAYA

457.75+1.99%
Market Cap
₹662.03 Cr
Stock P/E
-20.00
ROCE
0.00%
ROE
0.00%
Book Value
₹-51.83

Financials

YoY Net Sales
EPS Growth
Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

POSITIVES
  • NPS scores at 90 in Q1 FY ‘26 reflect strong customer experience.
  • Kaya Smiles contributed more than 90% of Kaya clinic collections in Q1 FY ‘26.
NEGATIVES
  • Standalone loss of Rs 14.2 crore in Q1 FY ’26 despite Rs 52.8 crore revenue, due to a prior-year one-time gain.
  • Metrics like clinic utilization are not disclosed publicly; response indicates further discussion would be private.

Peers Summary

Sector Leader

In the Hospital & Healthcare Services sector, Kaya Ltd. exhibits significant challenges with negative profitability metrics and low efficiency compared to its peers. Max Healthcare Institute and Apollo Hospitals Enterprise stand out as top performers, showcasing strong growth and profitability. Aster DM Healthcare presents a compelling value opportunity due to its low valuation metrics despite poor growth, while Fortis Healthcare is flagged as financially risky due to extremely high PE ratios.

Key Points
  • Kaya Ltd. has negative ROE, ROA, and profit margins, indicating financial distress.
  • Max Healthcare and Apollo Hospitals lead in revenue growth and profitability metrics.
  • Aster DM Healthcare is undervalued with a low PE ratio but has poor growth.
  • Fortis Healthcare is flagged for high PEs and low revenue growth, indicating financial risk.
Top Performers
Max Healthcare Institute Ltd.

Highest revenue growth (YoY and 3-Year) and strong profitability metrics.

Apollo Hospitals Enterprise Ltd.

Strong profitability with solid ROE and EPS growth.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.